In vitro antibacterial activity of DR-3355, the S-(-)-isomer of ofloxacin.
about
In vitro and in vivo antibacterial activities of levofloxacin (l-ofloxacin), an optically active ofloxacinActivity of levofloxacin in a murine model of tuberculosisScreening and its potential application of lipolytic activity from a marine environment: characterization of a novel esterase from Yarrowia lipolytica CL180.Characterization and its potential application of two esterases derived from the arctic sediment metagenome.Susceptibilities of bacterial isolates from patients with cancer to levofloxacin and other quinolones.Levofloxacin pharmacokinetics and serum bactericidal activities against five enterobacterial speciesLevofloxacin in vitro activity: results from an international comparative study with ofloxacin and ciprofloxacin.In vitro activity of T-3761, a new fluoroquinolonePrevalence of resistance to three fluoroquinolones: assessment of levofloxacin disk test error rates and surrogate predictors of levofloxacin susceptibility. AST Surveillance Group.Intestinal elimination of ofloxacin enantiomers in the rat: evidence of a carrier-mediated process.A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-acquired pneumonia.Effects of food and sucralfate on a single oral dose of 500 milligrams of levofloxacin in healthy subjectsPharmacokinetic study of ofloxacin enantiomers in Pagrosomus major by chiral HPLC.Novel 1-8-bridged chiral quinolones with activity against topoisomerase II: stereospecificity of the eukaryotic enzyme.Chiral separation of quinolones by liquid chromatography and capillary electrophoresis.Double-blind evaluation of the safety and pharmacokinetics of multiple oral once-daily 750-milligram and 1-gram doses of levofloxacin in healthy volunteers.In vitro and in vivo antibacterial activities of CS-940, a new 6-fluoro-8-difluoromethoxy quinolonePharmacokinetics and safety of oral levofloxacin in human immunodeficiency virus-infected individuals receiving concomitant zidovudine.Pharmacokinetic profile of levofloxacin following once-daily 500-milligram oral or intravenous dosesAbsorption of ofloxacin isomers in the rat small intestine.Enantioselective disposition of ofloxacin in humans.Pharmacokinetics of ofloxacin enantiomers after intravenous administration for antibiotic prophylaxis in biliary surgery.An integrated approach for detection and characterization of the trace impurities in levofloxacin using liquid chromatography-tandem mass spectrometry.Enantioselective disposition of clenbuterol in ratsSynthesis and Antibacterial Activity of Some Novel 4-Oxopyrido[2,3-a]phenothiazines
P2860
Q24671010-FBB95807-D765-4B47-8E5C-4D446780893DQ28369090-6BC61ED3-DEE4-4A5E-8AA8-E71A2D610B97Q30828107-552CB1DE-63E3-4CD3-9A07-53B4EAC02387Q33371586-C092947D-70B1-4034-9E07-446DAEB2B2F0Q33753316-669C3378-EE83-4A84-BBE3-809C66006AF7Q33981082-9301B790-BCCC-4D1D-9CA0-BC239F5CA2ABQ34333286-EFA55BB3-F477-43D4-A5E4-62DE3364135AQ34538060-21191AFB-D769-41DB-9765-F5B74E1D3DB7Q35125533-C5781A05-759B-47FD-9B9F-B1A09ED15D6BQ35126874-287A2D73-C888-4E0C-B717-063C4131108BQ35138146-C1384AB4-0894-4F55-B359-0D6FAA430B46Q35138534-C4304423-66F8-494C-B15E-4448FDCE9CFEQ35693178-6D05F348-6656-418E-9972-68B848D6023FQ35810950-1333C675-D708-4E4C-AB47-CE70819D40FEQ39311454-B730CE4D-4A29-4948-B7D5-CF11256E0038Q39557455-705ADA9E-5EC5-4AF2-AB95-5EB0AB0CF0E9Q39782054-500D5B85-D765-44C0-BB12-1BB631B72888Q39784736-399503CE-8BB7-4ECD-9D01-7FB8D3A4EEDCQ39785094-2062F9D4-86C6-4903-BF1A-BDEF92FA63B3Q39785111-A552156F-92E8-48ED-9F49-10274FFAF25DQ40087720-20BAC400-E188-45CE-B3A5-1540B2B715DAQ50186917-B64DF4E9-D046-4D02-A749-4F7B2AD07BE3Q53058971-143765E4-F5F6-4A5F-B1FE-E42888885D05Q57152532-7B82D6DD-0542-4529-9C0C-2C039605EAA5Q57787870-56D0BE22-3CA8-4671-AA7F-0C923BFA4E44
P2860
In vitro antibacterial activity of DR-3355, the S-(-)-isomer of ofloxacin.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh-hant
name
In vitro antibacterial activity of DR-3355, the S-(-)-isomer of ofloxacin.
@en
In vitro antibacterial activity of DR-3355, the S-(-)-isomer of ofloxacin.
@nl
type
label
In vitro antibacterial activity of DR-3355, the S-(-)-isomer of ofloxacin.
@en
In vitro antibacterial activity of DR-3355, the S-(-)-isomer of ofloxacin.
@nl
prefLabel
In vitro antibacterial activity of DR-3355, the S-(-)-isomer of ofloxacin.
@en
In vitro antibacterial activity of DR-3355, the S-(-)-isomer of ofloxacin.
@nl
P356
P1433
P1476
In vitro antibacterial activity of DR-3355, the S-(-)-isomer of ofloxacin.
@en
P2093
S Mitsuhashi
T Fujimoto
P304
P356
10.1159/000238777
P577
1990-01-01T00:00:00Z